Publié: 20 novembre 2024
Quality Assurance Technician (12 months)
Eysins
AliveDx
Jobs
3At AliveDx, our mission is to empower diagnostic insights, transform patient care, and innovate for life. We are poised to innovate diagnostics worldwide by putting the health of patients first, creating innovative solutions designed for faster disease detection to shorten the time to diagnosis. With more than 30-years in in-vitro diagnostics and best-in-class manufacturing of blood bank reagents, our product lines can help to make labs more efficient and clinical decision-making more effective. Our Alba blood bank reagents portfolio enables patients in need of a transfusion to have access to a safe and timely blood match as we facilitate both patient and donor blood screening. Our MosaiQ solution, an innovative multiplexing and multimodal solution, can help to bring about a diagnosis for patients by providing faster in-vitro test results. As an easy-to-use single solution, the platform performs multiple tests and gives maximum flexibility to laboratorians and clinicians. To inspire innovation, build more valuable products and create clinical and economic value, we are partnering with laboratorians and clinicians, patient advocacy groups, researchers, payers and industry partners. After decades operating as Alba Bioscience and most recently as Quotient, we continue to chart new pathways and innovate for life. When we ‘feel alive,’ we do more than just live. Feeling alive is giving purpose, meaning and energy to our communities, our work and ourselves.
Employé(e)s (0)
Candidat(e)s (0)
Traduit de l' anglais
19 juin 2019
Ancien(ne) employé(e)
Grand esprit d'équipe et excellente ambiance de travail ! Des gens très gentils et un état d'esprit. Quotient est un produit étonnant et il génère un environnement de travail très passionnant axé sur les affaires et l'innovation.
Quotient Suisse est encore dans une situation de vente pré-produit (comme dans une situation de start-up) et ne peut pas encore investir beaucoup dans le développement humain. Cela peut changer lorsque MosaiQ sera sur le marché. (commentaire rédigé le 19 juin)